Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 5,650,000 | 6,492,000 | 5,563,000 | 5,038,000 | 4,810,000 |
| Cost of Goods | 2,811,000 | 3,102,000 | 2,762,000 | 2,161,000 | 2,019,000 |
| Gross Profit | 2,839,000 | 3,390,000 | 2,801,000 | 2,877,000 | 2,791,000 |
| Operating Expenses | 1,944,000 | 3,948,000 | 2,446,000 | 1,804,000 | 1,507,000 |
| Operating Income | 895,000 | -558,000 | 355,000 | 1,073,000 | 1,284,000 |
| Other Income | -200,000 | -359,000 | 262,000 | -802,000 | -423,000 |
| Pre-tax Income | 695,000 | -917,000 | 617,000 | 271,000 | 861,000 |
| Income Tax | 54,000 | 57,000 | 207,000 | 29,000 | 228,000 |
| Net Income Continuous | 641,000 | -974,000 | 410,000 | 242,000 | 633,000 |
| Minority Interests | -4,000 | -1,000 | -2,000 | -12,000 | -3,000 |
| Net Income | $645,000 | $-973,000 | $412,000 | $254,000 | $636,000 |
| EPS Basic Total Ops | 0.57 | -1.11 | 0.35 | 0.21 | 0.62 |
| EPS Basic Continuous Ops | 0.63 | -1.05 | 0.42 | 0.26 | 0.69 |
| EPS Diluted Total Ops | 0.57 | -1.10 | 0.35 | 0.20 | 0.62 |
| EPS Diluted Continuous Ops | 0.63 | -1.04 | 0.42 | 0.26 | 0.69 |
| EBITDA(a) | $1,375,000 | $-226,000 | $932,000 | $1,383,000 | $1,589,000 |